IL111184A - Crystalline inclusion complex of diclofenac with unsubstituted beta-cyclodextrin - Google Patents
Crystalline inclusion complex of diclofenac with unsubstituted beta-cyclodextrinInfo
- Publication number
- IL111184A IL111184A IL11118494A IL11118494A IL111184A IL 111184 A IL111184 A IL 111184A IL 11118494 A IL11118494 A IL 11118494A IL 11118494 A IL11118494 A IL 11118494A IL 111184 A IL111184 A IL 111184A
- Authority
- IL
- Israel
- Prior art keywords
- diclofenac
- cyclodextrin
- inclusion complex
- unsubstituted beta
- crystalline inclusion
- Prior art date
Links
- 229920000858 Cyclodextrin Polymers 0.000 title abstract 3
- 239000001116 FEMA 4028 Substances 0.000 title abstract 3
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical class OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 title abstract 3
- 235000011175 beta-cyclodextrine Nutrition 0.000 title abstract 3
- 229960004853 betadex Drugs 0.000 title abstract 3
- 229960001259 diclofenac Drugs 0.000 title abstract 3
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 title abstract 3
- 229960001193 diclofenac sodium Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- JGMJQSFLQWGYMQ-UHFFFAOYSA-M sodium;2,6-dichloro-n-phenylaniline;acetate Chemical compound [Na+].CC([O-])=O.ClC1=CC=CC(Cl)=C1NC1=CC=CC=C1 JGMJQSFLQWGYMQ-UHFFFAOYSA-M 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nanotechnology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medical Informatics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ZA937480 | 1993-10-08 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL111184A0 IL111184A0 (en) | 1994-12-29 |
| IL111184A true IL111184A (en) | 2000-08-13 |
Family
ID=66767030
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL11118494A IL111184A (en) | 1993-10-08 | 1994-10-06 | Crystalline inclusion complex of diclofenac with unsubstituted beta-cyclodextrin |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US5674854A (de) |
| EP (1) | EP0647451B1 (de) |
| JP (1) | JPH07196484A (de) |
| KR (1) | KR950010910A (de) |
| CN (1) | CN1161115C (de) |
| AT (1) | ATE294593T1 (de) |
| AU (1) | AU682887B2 (de) |
| CA (1) | CA2133885C (de) |
| DE (1) | DE69434356T2 (de) |
| ES (1) | ES2240960T3 (de) |
| IL (1) | IL111184A (de) |
| ZA (1) | ZA948078B (de) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2735136B1 (fr) * | 1995-06-08 | 1997-08-14 | Roquette Freres | Composition pulverulente d'hydroxypropyl-betacyclodextrine et son procede de preparation. |
| HUP9600758A2 (en) * | 1996-03-27 | 1998-03-02 | Cyclolab Ciklodextrin Kutato F | Diclofenac composition of diminished gastrointestinal irritation and enhanced biological resorption |
| CA2341984A1 (en) * | 1999-07-01 | 2001-01-11 | Italfarmaco S.P.A. | Complexes of paroxetine, with cyclodextrines or cyclodextrin derivatives |
| US7049146B2 (en) | 2000-11-14 | 2006-05-23 | Facet Analytical Services And Technology, Llc | Calibration standards, methods, and kits for water determination |
| US7122376B2 (en) * | 2001-11-01 | 2006-10-17 | Facet Analytical Services And Technology, Llc | Calibration standards, methods, and kits for water determination |
| JP2005298338A (ja) * | 2002-02-27 | 2005-10-27 | Eisai Co Ltd | 速崩壊性圧縮成形製剤 |
| KR100473716B1 (ko) * | 2002-03-27 | 2005-03-08 | 주식회사 참 존 | 7-디하이드로콜레스테롤 및 사이클로덱스트린의 포접복합체, 이를 포함하는 화장료 조성물 및7-디하이드로콜레스테롤의 안정화방법 |
| AU2003270727A1 (en) * | 2002-09-17 | 2004-04-08 | Luna Innovations, Inc. | Remote temperature sensing of small volume and related apparatus thereof |
| FR2850040B1 (fr) * | 2003-01-20 | 2005-03-11 | Centre Nat Rech Scient | Systemes pour microencapsulation et leurs applications |
| PT1574221E (pt) * | 2004-03-10 | 2007-07-09 | Shimoda Biotech Pty Ltd | Composições de diclofenac injectáveis estáveis |
| PL2708225T3 (pl) * | 2004-04-23 | 2019-07-31 | Cydex Pharmaceuticals, Inc. | Formulacja DPI zawierająca eter sulfoalkilowy cyklodekstryny |
| US7629331B2 (en) | 2005-10-26 | 2009-12-08 | Cydex Pharmaceuticals, Inc. | Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof |
| EP2581078B1 (de) | 2005-10-26 | 2014-12-10 | Cydex Pharmaceuticals, Inc. | Sulfoalkylethercyclodextrin- Zusammensetzungen und deren Herstellungsverfahren |
| US20070267033A1 (en) * | 2006-02-09 | 2007-11-22 | Philip Morris Usa Inc. | Gamma cyclodextrin flavoring-release additives |
| EP2003970A4 (de) * | 2006-03-28 | 2012-07-11 | Javelin Pharmaceuticals Inc | Formulierungen aus niedrigdosierten nicht-steroiden entzündungshemmern und beta-cyclodextrin |
| AU2007230716B2 (en) | 2006-03-28 | 2012-05-03 | Javelin Pharmaceuticals, Inc. | Formulations of low dose diclofenac and beta-cyclodextrin |
| FR2912061A1 (fr) * | 2007-02-01 | 2008-08-08 | Aliscience Soc Par Actions Sim | Complexes d'inclusion de cysteine, leur presparation et les compositions les contenant |
| EP3257505A1 (de) * | 2011-07-20 | 2017-12-20 | Hospira, Inc. | Zusammensetzungen enthaltend diclofenac zur behandlung von postoperativen schmerzen |
| JP7758353B2 (ja) | 2020-03-23 | 2025-10-22 | クザップ リサーチ アンド デベロップメント エルエルシー | 経口テルペンシクロデキストリン包接体ビヒクル |
| GB202105833D0 (en) * | 2021-04-23 | 2021-06-09 | Nacamed As | Silicon particles for drug delivery |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5984821A (ja) * | 1982-11-04 | 1984-05-16 | Teikoku Chem Ind Corp Ltd | 徐溶化組成物 |
| IT1196033B (it) * | 1984-02-22 | 1988-11-10 | Chiesi Farma Spa | Composto ad attivita' antiinfiammatoria ottenuto per complessazione con beta-ciclodestrina e relative formulazioni farmaceutiche |
| US4845188A (en) * | 1988-08-19 | 1989-07-04 | Eastman Kodak Company | Condensation polymers containing methine ultraviolet radiation-absorbing residues and shaped articles produced therefrom |
| MY106598A (en) * | 1988-08-31 | 1995-06-30 | Australian Commercial Res & Development Ltd | Compositions and methods for drug delivery and chromatography. |
| IT1241088B (it) * | 1990-03-27 | 1993-12-29 | Chiesi Farma Spa | Procedimento per la preparazione di complessi piroxicam/ciclodestrina,prodotti ottenuti e loro composizioni farmaceutiche |
| IT1243342B (it) * | 1990-07-13 | 1994-06-10 | Farcon Ag | Composizioni farmaceutiche orali liquide ad attivita' antiinfiammatoria |
| EP1004318A3 (de) * | 1991-06-21 | 2002-08-07 | Takeda Chemical Industries, Ltd. | Zyklodextrin-zusammensetzung |
| DE4200792A1 (de) * | 1992-01-15 | 1993-07-22 | Solvay Fluor & Derivate | Aufarbeitung der fluorwasserstoff-phase aus reaktionsgemischen |
| JPH0616547A (ja) * | 1992-07-01 | 1994-01-25 | Wakamoto Pharmaceut Co Ltd | 消炎点眼剤 |
-
1994
- 1994-10-06 IL IL11118494A patent/IL111184A/xx not_active IP Right Cessation
- 1994-10-07 AT AT94307380T patent/ATE294593T1/de not_active IP Right Cessation
- 1994-10-07 DE DE69434356T patent/DE69434356T2/de not_active Expired - Lifetime
- 1994-10-07 ES ES94307380T patent/ES2240960T3/es not_active Expired - Lifetime
- 1994-10-07 EP EP94307380A patent/EP0647451B1/de not_active Expired - Lifetime
- 1994-10-07 CA CA002133885A patent/CA2133885C/en not_active Expired - Fee Related
- 1994-10-07 KR KR1019940025644A patent/KR950010910A/ko not_active Ceased
- 1994-10-07 US US08/319,548 patent/US5674854A/en not_active Expired - Lifetime
- 1994-10-07 AU AU74486/94A patent/AU682887B2/en not_active Ceased
- 1994-10-08 CN CNB941186768A patent/CN1161115C/zh not_active Expired - Fee Related
- 1994-10-11 JP JP6271715A patent/JPH07196484A/ja active Pending
- 1994-10-14 ZA ZA948078A patent/ZA948078B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL111184A0 (en) | 1994-12-29 |
| EP0647451B1 (de) | 2005-05-04 |
| KR950010910A (ko) | 1995-05-15 |
| AU682887B2 (en) | 1997-10-23 |
| CN1161115C (zh) | 2004-08-11 |
| DE69434356T2 (de) | 2006-05-04 |
| CA2133885C (en) | 2008-12-16 |
| ZA948078B (en) | 1995-06-05 |
| CN1107042A (zh) | 1995-08-23 |
| ATE294593T1 (de) | 2005-05-15 |
| DE69434356D1 (de) | 2005-06-09 |
| AU7448694A (en) | 1995-04-27 |
| CA2133885A1 (en) | 1995-04-09 |
| JPH07196484A (ja) | 1995-08-01 |
| US5674854A (en) | 1997-10-07 |
| EP0647451A1 (de) | 1995-04-12 |
| ES2240960T3 (es) | 2005-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA948078B (en) | Inclusion complex. | |
| GB9309324D0 (en) | Venzofuranyl-and-thiophenyl-alkanecarboxyclic acids derivatives | |
| AU8979191A (en) | 3,7-disubstituted indole derivatives | |
| IL112074A0 (en) | Branched-amino-substituted thiazoles, their preparation and pharmaceutical compositions containing them | |
| TW248559B (de) | ||
| GR3033350T3 (en) | Use of Beta-aminopropionic acid derivatives as fungicides | |
| AU562423B2 (en) | Benzoic acid derivatives | |
| DK0623620T3 (da) | 5-HT3-pyrrolopyrazinderivater | |
| AU2240388A (en) | Azachromane derivatives | |
| ES2023760A6 (es) | Procedimiento para la preparacion de derivados benzotiazinicos. | |
| AU686104B2 (en) | Substituted amidinonaphthyl ester derivatives | |
| AU563426B2 (en) | 3-alkoxy-2(n-pyrrolidino)-n-pyridyl-n-furyl (or thienyl) methyl propylamines | |
| AU8452591A (en) | 2-thio-1-aminocarbonyl cyclo alk-1-enes | |
| DE69108580D1 (de) | Optisch aktives Derivat der d-2-(6-Methoxy-2-naphthyl)-propionsäure und es enthaltende pharmazeutische Zusammensetzungen. | |
| FI960588A0 (fi) | Mikrobisideina käytettäviä tiokarbamoyyliyhdisteitä | |
| WO1995022544A3 (de) | Substituierte 1,3,8-triaza-spiro(4,5)-decan-4-on-derivate als vorstufen zur herstellung von pharmazeutika | |
| AU6797590A (en) | Improvements in or relating to organic compounds | |
| RU1807052C (ru) | 1,10-Фенантролинаты 4-нитрофенил-4 @ -пиридилметанидов натри или кали , обладающие индикаторными свойствами по отношению к воде или протонным органическим растворител м с интервалом перехода окраски от синей к бесцветной при рК @ 29 | |
| AU657684B2 (en) | Improvements in or relating to organic compounds | |
| BG50219A1 (en) | Cepheme derivatives containing a benzoxazolone cycle, and a method for their preparation | |
| AU2089292A (en) | Hydantoin derivatives | |
| IT1276893B1 (it) | 1,3,2-benzoossiazafosfolidine sostituite e procedimento per la loro preparazione | |
| IT1276892B1 (it) | 1,3,2-benzoossiazafosfolidine sostituite e procedimento per la loro preparazione |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |